نتائج البحث - Paul D. Kirchhoff

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    Electrostatic Influence on the Kinetics of Ligand Binding to Acetylcholinesterase

    Electrostatic Influence on the Kinetics of Ligand Binding to Acetylcholinesterase حسب Zoran Radić, Paul D. Kirchhoff, Daniel M. Quinn, J. Andrew McCammon, Palmer Taylor

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Inhibitors of TonB Function Identified by a High-Throughput Screen for Inhibitors of Iron Acquisition in Uropathogenic Escherichia coli CFT073

    Inhibitors of TonB Function Identified by a High-Throughput Screen for Inhibitors of Iron Acquisition in Uropathogenic Escherichia coli CFT073 حسب Alejandra Yep, Thomas J. McQuade, Paul D. Kirchhoff, Martha J. Larsen, Harry L. T. Mobley

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    X-ray Crystal Structures of the <i>Escherichia coli</i> RNA Polymerase in Complex with Benzoxazinorifamycins

    X-ray Crystal Structures of the <i>Escherichia coli</i> RNA Polymerase in Complex with Benzoxazinorifamycins حسب Vadim Molodtsov, Irosha N. Nawarathne, Nathan T. Scharf, Paul D. Kirchhoff, Hollis D. Showalter, George A. Garcia, Katsuhiko Murakami

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents

    Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents حسب Jessica L. Bell, Andrew J. Haak, Susan M. Wade, Paul D. Kirchhoff, Richard R. Neubig, Scott D. Larsen

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain

    Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain حسب Scott D. Larsen, Michael W. Wilson, Akira Abe, Liming Shu, Christopher H. George, Paul D. Kirchhoff, Hollis D. Showalter, Jianming Xiang, Richard F. Keep, James A. Shayman

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

    Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer حسب Weiguo Xiang, Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern, Yu Wang, Hoda Metwally, Paul D. Kirchhoff, Lu Wang, Aleksas Matvekas, Miao He, Bo Wen, Duxin Sun, Shaomeng Wang

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors

    Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors حسب Helen V. Waldschmidt, Kristoff T. Homan, Osvaldo Cruz-Rodríguez, M.C. Cato, Jessica Waninger‐Saroni, Kelly M. Larimore, Alessandro Cannavò, Jianliang Song, Joseph Y. Cheung, Paul D. Kirchhoff, Walter J. Koch, J.J.G. Tesmer, Scott D. Larsen

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

    Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy حسب Zhixiang Chen, Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern, Paul D. Kirchhoff, Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter Orth, Corey O. Strickland, E. Scott Priestley, Helai P. Mohammad, Meilin Wang, Bo Wen, Duxin Sun, Zhihua Sui, Shaomeng Wang

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer

    Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer حسب Weiguo Xiang, Lijie Zhao, Xin Han, Tianfeng Xu, Steven Kregel, Mi Wang, Bukeyan Miao, Chong Qin, Mingliang Wang, Donna McEachern, Jianfeng Lü, Longchuan Bai, Chao‐Yie Yang, Paul D. Kirchhoff, John Takyi‐Williams, Lu Wang, Bo Wen, Duxin Sun, Mark A. Ator, Robert McKean, Arul M. Chinnaiyan, Shaomeng Wang

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance

    Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance حسب Heng Lin, Kole Tison, Yuheng Du, Paul D. Kirchhoff, Chan Kim, Weichao Wang, Hannah Yang, Michael Pitter, Jiali Yu, Peng Liao, Jiajia Zhou, Linda Vatan, Sara Grove, Shuang Wei, Thomas M. Vigil, Yatrik M. Shah, Richard M. Mortensen, Ilona Kryczek, Lana X. Garmire, Jwala Priyadarsini Sivaccumar, Ashwin Ramesh, Ningyan Zhang, Zhiqiang An, Shaomeng Wang, Weiping Zou

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: